Literature DB >> 1884291

Effect of enrofloxacin on digoxin clearance and steady-state serum concentrations in dogs.

M J Novotny1, D H Shaw.   

Abstract

The effect of enrofloxacin on the oral clearance and steady-state concentrations of digoxin in serum was evaluated in dogs. Digoxin was administered orally to six healthy adult Beagle dogs following a multiple-dose regimen of 0.0625 mg every 12 h for 23 days. From days 14 to 23 enrofloxacin was administered orally at a dosage of 2.5 mg/kg every 12 h, with subjects receiving enrofloxacin 2 h prior to digoxin. Trough serum concentrations of digoxin were measured using an immunoassay technique. On days 13 and 22, dogs were catheterized for multiple blood sample collection during the 12 h digoxin dosing interval and serum samples were analyzed for digoxin concentrations. In general, steady-state digoxin concentrations in trough serum were not significantly different during enrofloxacin treatment than before enrofloxacin administration. Similarly, digoxin oral clearance was not significantly different between pre-enrofloxacin and digoxin + enrofloxacin periods. We conclude that enrofloxacin is unlikely to have a significant impact on digoxin disposition in dogs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1884291      PMCID: PMC1263429     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  20 in total

1.  Randomized study of intravenous versus sequential intravenous/oral regimen of ciprofloxacin in the treatment of gram-negative septicemia.

Authors:  D Gangji; F Jacobs; J de Jonckheer; L Coppens; E Serruys; F Hanotte; S Motte; J P Thys
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

2.  Inhibitory effect of enoxacin, ofloxacin and norfloxacin on renal excretion of theophylline in humans.

Authors:  M Sano; K Kawakatsu; I Yamamoto; M Takeyama; H Yamashina; M Goto
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Cyclosporine: prototype of a T-cell selective immunosuppressant.

Authors:  J V White
Journal:  J Am Vet Med Assoc       Date:  1986-09-01       Impact factor: 1.936

4.  Effect of aspirin, furosemide, and commercial low-salt diet on digoxin pharmacokinetic properties in clinically normal cats.

Authors:  C E Atkins; P S Snyder; B W Keene
Journal:  J Am Vet Med Assoc       Date:  1988-11-15       Impact factor: 1.936

5.  Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum.

Authors:  J Schwartz; L Jauregui; J Lettieri; K Bachmann
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

Review 6.  Symposium on antimicrobial agents. The quinolones.

Authors:  R C Walker; A J Wright
Journal:  Mayo Clin Proc       Date:  1987-11       Impact factor: 7.616

7.  Pharmacokinetics and interactions of digoxin with phenobarbital in dogs.

Authors:  W R Ravis; W M Pedersoli; J D Turco
Journal:  Am J Vet Res       Date:  1987-08       Impact factor: 1.156

8.  Inhibition of enoxacin absorption by antacids or ranitidine.

Authors:  T H Grasela; J J Schentag; A J Sedman; J H Wilton; D J Thomas; R W Schultz; M E Lebsack; A W Kinkel
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

Review 9.  Enrofloxacin: a new antimicrobial agent.

Authors:  J Schroder
Journal:  J S Afr Vet Assoc       Date:  1989-06       Impact factor: 1.474

Review 10.  Drug-drug interactions with ciprofloxacin and other fluoroquinolones.

Authors:  R E Polk
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.